carbostyril has been researched along with Dry Eye in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 26 (92.86) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CY; Chung, SH; Chung, TY; Eom, Y; Hyon, JY; Kim, HK; Kim, HM; Kim, JY; Kim, MK; Ko, BY; Lee, HK; Lee, JS; Seo, KY; Song, JS; Yoon, KC | 1 |
| Dogru, M; Kojima, T; Nakamura, S; Simsek, C; Tsubota, K | 1 |
| Alfuraih, S; Barbarino, A; Shamloo, K; Sharma, A | 1 |
| Fukagawa, K; Iwasaki, M; Okano, T; Saga, M; Sakata, M; Seika, D; Shimazaki, J | 1 |
| Fujimoto, C; Igarashi, T; Kobayashi, M; Suzuki, H; Takahashi, H; Yaguchi, C | 1 |
| Aoki, K; Dogru, M; Higa, K; Igarashi, A; Kojima, T; Shimazaki, J; Shimizu, T; Simsek, C; Tsubota, K | 1 |
| Ji, YW; Kang, HG; Kim, HC; Lee, HK; Moon, I; Noh, H; Song, JS; Yeo, A | 1 |
| Georgiev, GA; Yokoi, N | 1 |
| Watanabe, H | 1 |
| Hori, Y | 1 |
| Fu, R; Jiang, Y; Zhang, J; Zhou, J | 1 |
| Haruta, J; Kimura, K; Morita, Y; Orita, T; Sonoda, KH; Takeji, Y | 1 |
| Awamura, S; Kinoshita, S; Nakamichi, N; Oshiden, K; Suzuki, H; Yokoi, N | 3 |
| Inoue, Y; Koh, S; Maeda, N; Nishida, K; Sugmimoto, T | 1 |
| Ibrahim, OM; Ishida, S; Kawakita, T; Kojima, T; Nagata, T; Ohguchi, T; Satake, Y; Shimazaki, J; Shimizu, T; Shirasawa, T; Tsubota, K | 1 |
| Dogru, M; Ishida, R; Kaido, M; Tsubota, K | 1 |
| Messmer, EM | 1 |
| Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M | 1 |
| Igarashi, A; Kamiya, K; Kobashi, H; Shimizu, K | 1 |
| Maeda, Y; Matsumiya, W; Nagai, T; Nakamura, M; Otsuka, K; Ueda, K | 1 |
| Fujimoto, C; Fujita, M; Igarashi, T; Kobayashi, M; Nakano, Y; Suzuki, H; Takahashi, H; Yamada, Y | 1 |
| Akiyama-Fukuda, R; Usui, T; Yamagami, S; Yoshida, T | 1 |
| Ding, J; Kam, WR; Liu, Y; Sullivan, DA | 1 |
| Bielory, BP; Bielory, L; O'Brien, TP; Perez, VL; Shah, SP | 1 |
| Hiratsuka, Y; Kawashima, M; Shigeyasu, C; Suwaki, K; Tsubota, K; Uchino, M; Yamada, M; Yokoi, N | 1 |
| Dubois, D | 1 |
5 review(s) available for carbostyril and Dry Eye
| Article | Year |
|---|---|
Tear Film-Oriented Diagnosis and Tear Film-Oriented Therapy for Dry Eye Based on Tear Film Dynamics.
Topics: Alanine; Antioxidants; Dry Eye Syndromes; Humans; Japan; Mucins; Ophthalmic Solutions; Polyphosphates; Quinolones; Tears; Uracil Nucleotides; Wettability | 2018 |
Medical Treatment for Dry Eye in Japan.
Topics: Alanine; Dry Eye Syndromes; Humans; Japan; Lubricant Eye Drops; Polyphosphates; Quinolones; Tears; Uracil Nucleotides | 2018 |
Secreted Mucins on the Ocular Surface.
Topics: Alanine; Conjunctiva; Dry Eye Syndromes; Goblet Cells; Humans; Mucin 5AC; Ophthalmic Solutions; Polyphosphates; Quinolones; Uracil Nucleotides | 2018 |
Emerging therapeutics for ocular surface disease.
Topics: Animals; Antibodies, Monoclonal; Cytokines; Dry Eye Syndromes; Eye; Glucocorticoids; Humans; Hypersensitivity; Immunoglobulin E; Immunotherapy; Inflammation; Leukotriene Antagonists; Quinolones; Th1-Th2 Balance | 2016 |
Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
Topics: Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Cardiomyopathies; Child; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Drug Interactions; Drug Overdose; Dry Eye Syndromes; Humans; Hyperlipidemias; Hypotension; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2005 |
6 trial(s) available for carbostyril and Dry Eye
| Article | Year |
|---|---|
Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial.
Topics: Adult; Alanine; Dry Eye Syndromes; Humans; Middle Aged; Ophthalmic Solutions; Quinolones; Tears | 2023 |
A Prospective, Randomized Trial of Two Mucin Secretogogues for the Treatment of Dry Eye Syndrome in Office Workers.
Topics: Adult; Alanine; Conjunctiva; Dry Eye Syndromes; Female; Humans; Male; Middle Aged; Occupational Diseases; Polyphosphates; Prospective Studies; Quality of Life; Quinolones; Sclera; Secretagogues; Surveys and Questionnaires; Treatment Outcome; Uracil Nucleotides | 2017 |
A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Coloring Agents; Conjunctiva; Dry Eye Syndromes; Female; Fluorophotometry; Humans; Hyaluronic Acid; Lissamine Green Dyes; Male; Middle Aged; Ophthalmic Solutions; Quinolones; Tears; Treatment Outcome; Viscosupplements; Visual Acuity; Young Adult | 2013 |
Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery.
Topics: Administration, Topical; Adult; Alanine; Anti-Ulcer Agents; Dry Eye Syndromes; Female; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Light; Male; Middle Aged; Myopia; Postoperative Complications; Prospective Studies; Quinolones; Scattering, Radiation; Suspensions; Tears; Young Adult | 2015 |
Improvements in Signs and Symptoms of Dry Eye after Instillation of 2% Rebamipide.
Topics: Alanine; Dry Eye Syndromes; Female; Humans; Male; Ophthalmic Solutions; Quinolones; Treatment Outcome | 2015 |
Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antioxidants; Coloring Agents; Dose-Response Relationship, Drug; Double-Blind Method; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorophotometry; Humans; Lissamine Green Dyes; Male; Middle Aged; Ophthalmic Solutions; Quinolones; Treatment Outcome; Young Adult | 2012 |
17 other study(ies) available for carbostyril and Dry Eye
| Article | Year |
|---|---|
The Effects of Rebamipide 2% Ophthalmic Solution Application on Murine Subbasal Corneal Nerves After Environmental Dry Eye Stress.
Topics: Alanine; Animals; Anti-Inflammatory Agents; Cornea; Dry Eye Syndromes; Male; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Peripheral Nerves; Quinolones | 2019 |
Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
Topics: Administration, Ophthalmic; Alanine; Animals; Antioxidants; Bone Marrow Transplantation; CA-125 Antigen; Disease Models, Animal; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Eye Proteins; Female; Goblet Cells; Graft vs Host Disease; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Mucin 5AC; Mucin-1; Mucin-4; Mucins; Periodic Acid-Schiff Reaction; Quinolones; Real-Time Polymerase Chain Reaction; Tears; Transplantation, Homologous | 2019 |
Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye.
Topics: Adult; Alanine; Antioxidants; Contact Lenses, Hydrophilic; Cytokines; Dry Eye Syndromes; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Quinolones; Tears; Young Adult | 2018 |
The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice.
Topics: Alanine; Animals; Antioxidants; Biomarkers; Cell Differentiation; Conjunctiva; Disease Models, Animal; Dry Eye Syndromes; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Ophthalmic Solutions; Quinolones; RNA, Messenger; Superoxide Dismutase-1; Tears | 2018 |
Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model.
Topics: Administration, Topical; Alanine; Animals; Anti-Inflammatory Agents; Cyclosporine; Disease Models, Animal; Dry Eye Syndromes; Epithelium, Corneal; Female; Inflammation; Mice; Mice, Inbred C57BL; Mucins; Ophthalmic Solutions; Polyphosphates; Quinolones; Uracil Nucleotides | 2018 |
Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice.
Topics: Alanine; Animals; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Lacrimal Apparatus; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Quinolones; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |
Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide.
Topics: Adherens Junctions; Alanine; Animals; Antioxidants; beta Catenin; Cadherins; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Dry Eye Syndromes; Electric Impedance; Epithelium, Corneal; Fluorescent Antibody Technique, Indirect; Humans; I-kappa B Proteins; Immunoblotting; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Occludin; Ophthalmic Solutions; Phosphorylation; Quinolones; Rats; Rats, Sprague-Dawley; Tight Junctions; Tumor Necrosis Factor-alpha; Wound Healing; Zonula Occludens-1 Protein | 2013 |
Effect of rebamipide ophthalmic suspension on optical quality in the short break-up time type of dry eye.
Topics: Aberrometry; Adult; Aged; Aged, 80 and over; Alanine; Antioxidants; Corneal Topography; Corneal Wavefront Aberration; Dry Eye Syndromes; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Quinolones; Tears; Visual Acuity | 2013 |
The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
Topics: Alanine; Animals; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Dry Eye Syndromes; Enzyme Inhibitors; Male; Mice; Mice, Knockout; Ophthalmic Solutions; Quinolones; Superoxide Dismutase; Superoxide Dismutase-1; Tears | 2013 |
A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antioxidants; Cornea; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Quinolones; Staining and Labeling; Suspensions; Tears; Time Factors; Treatment Outcome; Visual Acuity; Young Adult | 2014 |
Short-term effects of instillation of a rebamipide suspension on visual function.
Topics: Adult; Alanine; Dry Eye Syndromes; Female; Humans; Instillation, Drug; Male; Middle Aged; Ophthalmic Solutions; Quinolones; Suspensions; Tears; Vision, Ocular; Visual Acuity | 2014 |
[New therapeutic options for dry eye].
Topics: Alanine; Animals; Anti-Ulcer Agents; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Humans; Hyaluronic Acid; Hydroxamic Acids; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Lymphocyte Function-Associated Antigen-1; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Molecular Targeted Therapy; Ophthalmic Solutions; Polyphosphates; Quinolones; Sulfonamides; Uracil Nucleotides; Viscosupplements | 2014 |
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Graft vs Host Disease; Humans; Middle Aged; Ophthalmic Solutions; Pemphigoid, Benign Mucous Membrane; Polyphosphates; Purinergic P2Y Receptor Agonists; Quinolones; Treatment Outcome; Uracil Nucleotides; Visual Acuity | 2015 |
Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.
Topics: Aged; Alanine; Antioxidants; Cornea; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Ophthalmic Solutions; Quinolones; Retrospective Studies; Suspensions | 2015 |
Evaluation of Tear Meniscus Dynamics Using Anterior Segment Swept-Source Optical Coherence Tomography After Topical Solution Instillation for Dry Eye.
Topics: Administration, Topical; Adult; Alanine; Anterior Eye Segment; Cross-Sectional Studies; Dry Eye Syndromes; Female; Humans; Hyaluronic Acid; Male; Ophthalmic Solutions; Polyphosphates; Prospective Studies; Quinolones; Tears; Tomography, Optical Coherence; Uracil Nucleotides | 2016 |
Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells?
Topics: Alanine; Antihypertensive Agents; Antioxidants; Antirheumatic Agents; Bimatoprost; Cell Count; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclosporine; Dry Eye Syndromes; Epithelial Cells; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Meibomian Glands; Quinolones; Signal Transduction; Uridine Triphosphate | 2016 |
A Clinic-based Survey of Clinical Characteristics and Practice Pattern of Dry Eye in Japan.
Topics: Aged; Alanine; Cross-Sectional Studies; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Humans; Hyaluronic Acid; Japan; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Practice Patterns, Physicians'; Prevalence; Quinolones; Symptom Assessment; Treatment Outcome; Uracil Nucleotides | 2017 |